Comment on "Refracture risk and all-cause mortality after vertebral fragility fractures: Anti-osteoporotic medications matter"
J Formos Med Assoc
.
2023:122 Suppl 1:S101-S102.
doi: 10.1016/j.jfma.2023.07.008.
Epub 2023 Jul 18.
Authors
Peng Qu
1
,
Hongyan Hao
1
,
Xueliang Zhang
2
Affiliations
1
Department of Orthopedics, The First Hospital of Lanzhou University, Lanzhou City 730000, Gansu, China.
2
Department of Orthopedics, The First Hospital of Lanzhou University, Lanzhou City 730000, Gansu, China. Electronic address: qupeng6215@163.com.
PMID:
37468408
DOI:
10.1016/j.jfma.2023.07.008
No abstract available
Publication types
Letter